Researchers have documented the safety profile observed in published Phase 2 research as predominantly gastrointestinal effects (nausea, diarrhoea, vomiting) typical of the incretin class, occurring most prominently during dose escalation and tending to decline with continued exposure (PMID 39515565, PMID 41785010)
A consistent downward trend of 0.5 to 1.5 percent of body weight per week while on a therapeutic dose is a typical range
Partial recovery is possible with medical care, but some damage may be permanent
While ascorbic acid is the most common form of vitamin C, the human body can only absorb a limited amount at one time
The Pure Glow Fusion is a longevity + recovery-focused peptide blend designed to support the things people usually care about most: healthier-looking skin, faster recovery, and better overall resilience
Your clinical team will increase your dose gradually based on tolerance and responsetypically by 0.25 mg weekly over several weeksbut your flat monthly investment remains unchanged